• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
OTC Healthcare in the Netherlands to 2014 Product Image

OTC Healthcare in the Netherlands to 2014

  • Published: July 2010
  • Region: Netherlands, Holland
  • 170 pages
  • Datamonitor

This databook provides key data and information on the OTC healthcare market in the Netherlands. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.

Scope

- Contains information on:analgesics,medicated skinproduct,topicalOTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits

- Market,category and segment level information on value with historic (2004-09) and forecast (2010-14) data

- Category level company and brand share as well as distribution share information for 2008 and 2009

- Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description

Highlights of this title

The market for OTC healthcare in the Netherlands increased at a compound annual growth rate of 2.4% between 2004 and 2009.

The vitamins and minerals category led the OTC healthcare market in the Netherlands, accounting for a share of 21.5%.

Leading players in Dutch OTC healthcare market include Johnson & Johnson, Bayer AG and Novartis AG.

Key reasons READ MORE >



Chapter 1 Executive Summary
Summary market level: OTC healthcare
Summary category level: analgesics
Summary category level: topical OTC medicines
Summary category level: cough and cold preparations
Summary category level: indigestion preparations
Summary category level: medicated skin products
Summary category level: first aid kits
Summary category level: other OTC healthcare products
Summary category level: plasters & bandages
Summary category level: traditional medicines
Summary category level: vitamins and minerals

Chapter 2 Introduction
What is this report about?
How to use this report
Market definition

Chapter 3 Market Overview
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 4 Leading Company Profiles
Johnson & Johnson
Bayer AG

Chapter 5 Category Analysis: Analgesics
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 6 Category Analysis: Topical OTC Medicines
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 7 Category Analysis: Cough and Cold Preparations
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 8 Category Analysis: Indigestion Preparations
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 9 Category Analysis: Medicated Skin Products
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 10 Category Analysis: First Aid Kits
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 11 Category Analysis: Other OTC Healthcare Products
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 12 Category Analysis: Plasters & Bandages
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 13 Category Analysis: Traditional Medicines
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 14 Category Analysis: Vitamins and Minerals
Value analysis (Euro), 2004-09
Value analysis (Euro), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 15 Country Comparison
Value
Market share

Chapter 16 New Product Development
Product launches over time
Recent product launches

Chapter 17 Macroeconomic Profile
Macroeconomic Indicators

Chapter 18 Research Methodology
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research

Chapter 19 Appendix
Future readings
How to contact experts in your industry
Disclaimer

LIST OF FIGURES
Figure 1: OTC healthcare, Netherlands, value by category (€m), 2004-14
Figure 2: OTC healthcare, Netherlands, category growth comparison, by value, 2004-14
Figure 3: OTC healthcare, Netherlands, company share by value (%), 2008-09
Figure 4: OTC healthcare, Netherlands, distribution channels by value (%), 2008-09
Figure 5: Analgesics, Netherlands, value by segment (€m), 2004-14
Figure 6: Analgesics, Netherlands, category growth comparison, by value, 2004-14
Figure 7: Analgesics, Netherlands, company share by value (%), 2008-09
Figure 8: Analgesics, Netherlands, distribution channels by value (%), 2008-09
Figure 9: Topical OTC medicines, Netherlands, value by segment (€m), 2004-14
Figure 10: Topical OTC medicines, Netherlands, category growth comparison, by value, 2004-14
Figure 11: Topical OTC medicines, Netherlands, distribution channels by value (%), 2008-09
Figure 12: Cough and cold preparations, Netherlands, value by segment (€m), 2004-14
Figure 13: Cough and cold preparations, Netherlands, category growth comparison, by value, 2004-14
Figure 14: Cough and cold preparations, Netherlands, company share by value (%), 2008-09
Figure 15: Cough and cold preparations, Netherlands, distribution channels by value (%), 2008-09
Figure 16: Indigestion preparations, Netherlands, value by segment (€m), 2004-14
Figure 17: Indigestion preparations, Netherlands, category growth comparison, by value, 2004-14
Figure 18: Indigestion preparations, Netherlands, company share by value (%), 2008-09
Figure 19: Indigestion preparations, Netherlands, distribution channels by value (%), 2008-09
Figure 20: Medicated skin products, Netherlands, value by segment (€m), 2004-14
Figure 21: Medicated skin products, Netherlands, category growth comparison, by value, 2004-14
Figure 22: Medicated skin products, Netherlands, company share by value (%), 2008-09
Figure 23: Medicated skin products, Netherlands, distribution channels by value (%), 2008-09
Figure 24: First aid kits, Netherlands, value (€m), 2004-14
Figure 25: First aid kits, Netherlands, company share by value (%), 2008-09
Figure 26: First aid kits, Netherlands, distribution channels by value (%), 2008-09
Figure 27: Other OTC healthcare products, Netherlands, value by segment (€m), 2004-14
Figure 28: Other OTC healthcare products, Netherlands, category growth comparison, by value, 2004-14
Figure 29: Other OTC healthcare products, Netherlands, company share by value (%), 2008-09
Figure 30: Other OTC healthcare products, Netherlands, distribution channels by value (%), 2008-09
Figure 31: Plasters & bandages, Netherlands, value by segment (€m), 2004-14
Figure 32: Plasters & bandages, Netherlands, category growth comparison, by value, 2004-14
Figure 33: Plasters & bandages, Netherlands, company share by value (%), 2008-09
Figure 34: Plasters & bandages, Netherlands, distribution channels by value (%), 2008-09
Figure 35: Traditional medicines, Netherlands, value (€m), 2004-14
Figure 36: Traditional medicines, Netherlands, company share by value (%), 2008-09
Figure 37: Traditional medicines, Netherlands, distribution channels by value (%), 2008-09
Figure 38: Vitamins and minerals, Netherlands, value by segment (€m), 2004-14
Figure 39: Vitamins and minerals, Netherlands, category growth comparison, by value, 2004-14
Figure 40: Vitamins and minerals, Netherlands, company share by value (%), 2008-09
Figure 41: Vitamins and minerals, Netherlands, distribution channels by value (%), 2008-09
Figure 42: Global OTC healthcare market split (value terms, 2009), top five countries
Figure 43: Global OTC healthcare market value, 2004-09, top five countries
Figure 44: Annual data review process

LIST OF TABLES
Table 1: OTC healthcare category definitions
Table 2: OTC healthcare distribution channels
Table 3: OTC healthcare, Netherlands, value by category (€m), 2004-09
Table 4: OTC healthcare, Netherlands, value forecast by category (€m), 2009-14
Table 5: OTC healthcare, Netherlands, value by category ($m), 2004-09
Table 6: OTC healthcare, Netherlands, value forecast by category ($m), 2009-14
Table 7: OTC healthcare, Netherlands, brand share by value (%), 2008-09
Table 8: OTC healthcare, Netherlands, value by brand (€m), 2008-09
Table 9: OTC healthcare, Netherlands, company share by value (%), 2008-09
Table 10: OTC healthcare, Netherlands, value by company (€m), 2008-09
Table 11: OTC healthcare, Netherlands, distribution channels by value (%), 2008-09
Table 12: OTC healthcare, Netherlands, value by distribution channel (€m), 2008-09
Table 13: Johnson & Johnson key facts
Table 14: Bayer AG key facts
Table 15: Analgesics, Netherlands, value by segment (€m), 2004-09
Table 16: Analgesics, Netherlands, value forecast by segment (€m), 2009-14
Table 17: Analgesics, Netherlands, value by segment ($m), 2004-09
Table 18: Analgesics, Netherlands, value forecast by segment ($m), 2009-14
Table 19: Analgesics, Netherlands, brand share by value (%), 2008-09
Table 20: Analgesics, Netherlands, value by brand (€m), 2008-09
Table 21: Analgesics, Netherlands, company share by value (%), 2008-09
Table 22: Analgesics, Netherlands, value by company (€m), 2008-09
Table 23: Analgesics, Netherlands, distribution channels by value (%), 2008-09
Table 24: Analgesics, Netherlands, value by distribution channel (€m), 2008-09
Table 25: Topical OTC medicines, Netherlands, value by segment (€m), 2004-09
Table 26: Topical OTC medicines, Netherlands, value forecast by segment (€m), 2009-14
Table 27: Topical OTC medicines, Netherlands, value by segment ($m), 2004-09
Table 28: Topical OTC medicines, Netherlands, value forecast by segment ($m), 2009-14
Table 29: Topical OTC medicines, Netherlands, brand share by value (%), 2008-09
Table 30: Topical OTC medicines, Netherlands, value by brand (€m), 2008-09
Table 31: Topical OTC medicines, Netherlands, company share by value (%), 2008-09
Table 32: Topical OTC medicines, Netherlands, value by company (€m), 2008-09
Table 33: Topical OTC medicines, Netherlands, distribution channels by value (%), 2008-09
Table 34: Topical OTC medicines, Netherlands, value by distribution channel (€m), 2008-09
Table 35: Cough and cold preparations, Netherlands, value by segment (€m), 2004-09
Table 36: Cough and cold preparations, Netherlands, value forecast by segment (€m), 2009-14
Table 37: Cough and cold preparations, Netherlands, value by segment ($m), 2004-09
Table 38: Cough and cold preparations, Netherlands, value forecast by segment ($m), 2009-14
Table 39: Cough and cold preparations, Netherlands, brand share by value (%), 2008-09
Table 40: Cough and cold preparations, Netherlands, value by brand (€m), 2008-09
Table 41: Cough and cold preparations, Netherlands, company share by value (%), 2008-09
Table 42: Cough and cold preparations, Netherlands, value by company (€m), 2008-09
Table 43: Cough and cold preparations, Netherlands, distribution channels by value (%), 2008-09
Table 44: Cough and cold preparations, Netherlands, value by distribution channel (€m), 2008-09
Table 45: Indigestion preparations, Netherlands, value by segment (€m), 2004-09
Table 46: Indigestion preparations, Netherlands, value forecast by segment (€m), 2009-14
Table 47: Indigestion preparations, Netherlands, value by segment ($m), 2004-09
Table 48: Indigestion preparations, Netherlands, value forecast by segment ($m), 2009-14
Table 49: Indigestion preparations, Netherlands, brand share by value (%), 2008-09
Table 50: Indigestion preparations, Netherlands, value by brand (€m), 2008-09
Table 51: Indigestion preparations, Netherlands, company share by value (%), 2008-09
Table 52: Indigestion preparations, Netherlands, value by company (€m), 2008-09
Table 53: Indigestion preparations, Netherlands, distribution channels by value (%), 2008-09
Table 54: Indigestion preparations, Netherlands, value by distribution channel (€m), 2008-09
Table 55: Medicated skin products, Netherlands, value by segment (€m), 2004-09
Table 56: Medicated skin products, Netherlands, value forecast by segment (€m), 2009-14
Table 57: Medicated skin products, Netherlands, value by segment ($m), 2004-09
Table 58: Medicated skin products, Netherlands, value forecast by segment ($m), 2009-14
Table 59: Medicated skin products, Netherlands, brand share by value (%), 2008-09
Table 60: Medicated skin products, Netherlands, value by brand (€m), 2008-09
Table 61: Medicated skin products, Netherlands, company share by value (%), 2008-09
Table 62: Medicated skin products, Netherlands, value by company (€m), 2008-09
Table 63: Medicated skin products, Netherlands, distribution channels by value (%), 2008-09
Table 64: Medicated skin products, Netherlands, value by distribution channel (€m), 2008-09
Table 65: First aid kits, Netherlands, value (€m), 2004-09
Table 66: First aid kits, Netherlands, value forecast (€m), 2009-14
Table 67: First aid kits, Netherlands, value ($m), 2004-09
Table 68: First aid kits, Netherlands, value forecast ($m), 2009-14
Table 69: First aid kits, Netherlands, brand share by value (%), 2008-09
Table 70: First aid kits, Netherlands, value by brand (€m), 2008-09
Table 71: First aid kits, Netherlands, company share by value (%), 2008-09
Table 72: First aid kits, Netherlands, value by company (€m), 2008-09
Table 73: First aid kits, Netherlands, distribution channels by value (%), 2008-09
Table 74: First aid kits, Netherlands, value by distribution channel (€m), 2008-09
Table 75: Other OTC healthcare products, Netherlands, value by segment (€m), 2004-09
Table 76: Other OTC healthcare products, Netherlands, value forecast by segment (€m), 2009-14
Table 77: Other OTC healthcare products, Netherlands, value by segment ($m), 2004-09
Table 78: Other OTC healthcare products, Netherlands, value forecast by segment ($m), 2009-14
Table 79: Other OTC healthcare products, Netherlands, brand share by value (%), 2008-09
Table 80: Other OTC healthcare products, Netherlands, value by brand (€m), 2008-09
Table 81: Other OTC healthcare products, Netherlands, company share by value (%), 2008-09
Table 82: Other OTC healthcare products, Netherlands, value by company (€m), 2008-09
Table 83: Other OTC healthcare products, Netherlands, distribution channels by value (%), 2008-09
Table 84: Other OTC healthcare products, Netherlands, value by distribution channel (€m), 2008-09
Table 85: Plasters & bandages, Netherlands, value by segment (€m), 2004-09
Table 86: Plasters & bandages, Netherlands, value forecast by segment (€m), 2009-14
Table 87: Plasters & bandages, Netherlands, value by segment ($m), 2004-09
Table 88: Plasters & bandages, Netherlands, value forecast by segment ($m), 2009-14
Table 89: Plasters & bandages, Netherlands, brand share by value (%), 2008-09
Table 90: Plasters & bandages, Netherlands, value by brand (€m), 2008-09
Table 91: Plasters & bandages, Netherlands, company share by value (%), 2008-09
Table 92: Plasters & bandages, Netherlands, value by company (€m), 2008-09
Table 93: Plasters & bandages, Netherlands, distribution channels by value (%), 2008-09
Table 94: Plasters & bandages, Netherlands, value by distribution channel (€m), 2008-09
Table 95: Traditional medicines, Netherlands, value (€m), 2004-09
Table 96: Traditional medicines, Netherlands, value forecast (€m), 2009-14
Table 97: Traditional medicines, Netherlands, value ($m), 2004-09
Table 98: Traditional medicines, Netherlands, value forecast ($m), 2009-14
Table 99: Traditional medicines, Netherlands, brand share by value (%), 2008-09
Table 100: Traditional medicines, Netherlands, value by brand (€m), 2008-09
Table 101: Traditional medicines, Netherlands, company share by value (%), 2008-09
Table 102: Traditional medicines, Netherlands, value by company (€m), 2008-09
Table 103: Traditional medicines, Netherlands, distribution channels by value (%), 2008-09
Table 104: Traditional medicines, Netherlands, value by distribution channel (€m), 2008-09
Table 105: Vitamins and minerals, Netherlands, value by segment (€m), 2004-09
Table 106: Vitamins and minerals, Netherlands, value forecast by segment (€m), 2009-14
Table 107: Vitamins and minerals, Netherlands, value by segment ($m), 2004-09
Table 108: Vitamins and minerals, Netherlands, value forecast by segment ($m), 2009-14
Table 109: Vitamins and minerals, Netherlands, brand share by value (%), 2008-09
Table 110: Vitamins and minerals, Netherlands, value by brand (€m), 2008-09
Table 111: Vitamins and minerals, Netherlands, company share by value (%), 2008-09
Table 112: Vitamins and minerals, Netherlands, value by company (€m), 2008-09
Table 113: Vitamins and minerals, Netherlands, distribution channels by value (%), 2008-09
Table 114: Vitamins and minerals, Netherlands, value by distribution channel (€m), 2008-09
Table 115: Global OTC healthcare market value, 2009
Table 116: Global OTC healthcare market split (value terms ($m), 2009), top five countries
Table 117: Leading players, top five countries
Table 118: Netherlands OTC healthcare new product launches reports, by company (top five companies), 2009
Table 119: Netherlands OTC healthcare new product launches SKUs, by company (top five companies), 2009
Table 120: Netherlands OTC healthcare new product launches (reports), by flavor and fragrances, 2009
Table 121: Netherlands OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2009
Table 122: Netherlands OTC healthcare new product launches (reports), by package tags or claims (top 10 claims), 2009
Table 123: Netherlands OTC healthcare new product launches - recent five launches (2009)
Table 124: Netherlands population, by age group, 2004-09 (millions)
Table 125: Netherlands population forecast, by age group, 2009-14 (millions)
Table 126: Netherlands population, by gender, 2004-09 (millions)
Table 127: Netherlands population forecast, by gender, 2009-14 (millions)
Table 128: Netherlands nominal GDP, 2004-09 (€bn, nominal prices)
Table 129: Netherlands nominal GDP forecast, 2009-14 (€bn, nominal prices)
Table 130: Netherlands real GDP, 2004-09 (€bn, 2000 prices)
Table 131: Netherlands real GDP forecast, 2009-14 (€bn, 2000 prices)
Table 132: Netherlands real GDP, 2004-09 ($bn, 2000 prices)
Table 133: Netherlands real GDP forecast, 2009-14 ($bn, 2000 prices)
Table 134: Netherlands consumer price index, 2004-09 (2000=100)
Table 135: Netherlands consumer price index, 2009-14 (2000=100)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos